Proliferating NK cells in response to IL-15 do not upregulate surface B220 in vivo.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Works matching IS 09697128 AND DT 2010 AND VI 17 AND IP 5
Results: 14
1
2
Studies on protective effects of human paraoxonases 1 and 3 on atherosclerosis in apolipoprotein E knockout mice.
- Published in:
- Gene Therapy, 2010, v. 17, n. 5, p. 626, doi. 10.1038/gt.2010.11
- By:
- Publication type:
- Article
3
Insulin expressed from endogenously active glucose-responsive EGR1 promoter in bone marrow mesenchymal stromal cells as diabetes therapy.
- Published in:
- Gene Therapy, 2010, v. 17, n. 5, p. 592, doi. 10.1038/gt.2010.12
- By:
- Publication type:
- Article
4
A dual promoter lentiviral vector for the in vivo evaluation of gene therapeutic approaches to axon regeneration after spinal cord injury.
- Published in:
- Gene Therapy, 2010, v. 17, n. 5, p. 577, doi. 10.1038/gt.2010.14
- By:
- Publication type:
- Article
5
Adeno-associated virus-mediated delivery of kringle 5 of human plasminogen inhibits orthotopic growth of ovarian cancer.
- Published in:
- Gene Therapy, 2010, v. 17, n. 5, p. 606, doi. 10.1038/gt.2010.15
- By:
- Publication type:
- Article
6
Evaluation of cross-reactive cell-mediated immune responses among human, bovine and porcine adenoviruses.
- Published in:
- Gene Therapy, 2010, v. 17, n. 5, p. 634, doi. 10.1038/gt.2010.1
- By:
- Publication type:
- Article
7
Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen.
- Published in:
- Gene Therapy, 2010, v. 17, n. 5, p. 678, doi. 10.1038/gt.2010.21
- By:
- Publication type:
- Article
8
Anticonvulsant effects and behavioural outcomes of rAAV serotype 1 vector-mediated neuropeptide Y overexpression in rat hippocampus.
- Published in:
- Gene Therapy, 2010, v. 17, n. 5, p. 643, doi. 10.1038/gt.2010.23
- By:
- Publication type:
- Article
9
Rhadinovirus vector-derived human telomerase reverse transcriptase expression in primary T cells.
- Published in:
- Gene Therapy, 2010, v. 17, n. 5, p. 653, doi. 10.1038/gt.2010.3
- By:
- Publication type:
- Article
10
Progress and prospects: Immunobiology of gene therapy for neurodegenerative disease: prospects and risks.
- Published in:
- 2010
- By:
- Publication type:
- Correction Notice
11
Lack of humoral immune response to the tetracycline (Tet) activator in rats injected intracranially with Tet-off rAAV vectors.
- Published in:
- Gene Therapy, 2010, v. 17, n. 5, p. 616, doi. 10.1038/gt.2010.6
- By:
- Publication type:
- Article
12
Lentiviral vectors incorporating a human elongation factor 1α promoter for the treatment of canine leukocyte adhesion deficiency.
- Published in:
- Gene Therapy, 2010, v. 17, n. 5, p. 672, doi. 10.1038/gt.2010.7
- By:
- Publication type:
- Article
13
IL-10 delivery by AAV5 vector attenuates inflammation in mice with pseudomonas pneumonia.
- Published in:
- Gene Therapy, 2010, v. 17, n. 5, p. 567, doi. 10.1038/gt.2010.28
- By:
- Publication type:
- Article
14
Anti-inflammatory effect by lentiviral-mediated overexpression of IL-10 or IL-1 receptor antagonist in rat glial cells and macrophages.
- Published in:
- Gene Therapy, 2010, v. 17, n. 5, p. 662, doi. 10.1038/gt.2010.8
- By:
- Publication type:
- Article